Nov 11, 2020 / 07:45PM GMT
Jo Walton - Crédit Suisse AG - Research Division - MD
Good afternoon, and good evening. It's my pleasure -- I'm Jo Walton, and it's my pleasure with my colleague Matthew Weston here to introduce Dietmar Berger as our speaker from Sanofi. We also have the main Sanofi IR team available should we have any broader questions.
Dietmar is the Head of -- Global Head of Clinical Development and the Chief Medical Officer. He has had wide experience before joining Sanofi in 2019. And in fact, coming back to Sanofi or coming to Sanofi here, he works once again with John Reed, who he worked with at Roche.
Questions and Answers:
Jo Walton - Crédit Suisse AG - Research Division - MDI'm going to start with a broad question on R&D. And then we're going to move on to look at some of the individual products. We've had an extensive disclosure this summer through a series of R&D meetings, and we're hoping to build on that disclosure with more Q&A today.
So firstly, my question to you is
Trustpilot
